TRUHVaneck Healthcare TruSector ETF
Seeks long-term capital appreciation.
By VanEck · Launched 2026
Annual Cost
0.10%
#408 of 5,853 · low cost
Fund Size
$0.8M
#5,673 of 5,853 · small
Return (1Y)Goal
N/A
Track Record
4 months
#5,325 of 5,853 · young
Performance
Total-return NAV · USDGrowth of $10,000
$11,168+11.7%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 60.6% of fundconcentrated
Eli Lilly and CoLLY
16.1%
Johnson & JohnsonJNJ
10.0%
AbbVie IncABBV
7.1%
UnitedHealth Group IncUNH
6.4%
Merck & Co IncMRK
5.5%
Thermo Fisher Scientific IncTMO
3.4%
Amgen IncAMGN
3.4%
Gilead Sciences IncGILD
3.1%
Intuitive Surgical IncISRG
2.8%
Pfizer IncPFE
2.8%
Asset allocation
Stocks
99.6%
Cash
0.4%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
N/A
Max drawdown
-4.5%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NASDAQ Global Select Market
Full fund details
- Objective
- Seeks long-term capital appreciation.
- Strategy
- Actively manages a portfolio primarily invested in equity securities of U.S. healthcare-related companies, focusing on large- and medium-capitalization firms. The Adviser favors well-established market leaders and may use derivatives for exposure, with a concentration in the healthcare sector.
- Inception date
- April 1, 2026
- Fund family
- VanEck
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at TRUH. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-02